CSF2 and cancer: The efficacy is still debated because GM-CSF activates both anti-cancer immunity and recruitment of cancer-promoting immune cells depending on the subsets of ICI in the cancer microenvironment (Berraondo et al., 2019; Cuzzubbo et al., 2020; Garner & de Visser, 2020; Kumar et al., 2022).